EGFR and glioblastoma: Although such mechanisms have not yet been described in GBM, the intrinsic plasticity of glioblastoma stem cells and the frequent activation of bypass pathways (e.g., EGFR, MET, PDGFR) suggest that resistance could also emerge in this context.